In advance of the pending October 2 MIPS reporting deadline, Rx.Health has entered into a strategic partnership with MyMipsScore in order to deliver next-generation quality improvement solutions for health systems and specialty providers to excel under value-based reimbursement models. The combined offering now enables organizations to analyze all 271 quality measures and compare them across all benchmarks in real time. MyMipsScore also includes ACI and IA performance scores to calculate your Composite Performance Score (CPS), which is commonly known as MIPS Score. Read the full press release here.
“Even though maximizing a MIPS score has potential to provide substantive rewards for providers, most practitioners are completely unprepared for the fast-approaching October deadline,” said Rx.Health CEO Ed Berde. “By partnering with MyMipsScore, we are able to immediately and seamlessly provide clinicians with a complete toolkit to take full advantage of reimbursements while avoiding needless penalties as we move into 2018.”
While most practitioners are focused on avoiding the penalty, they are not aware of the potential bonus they can earn under MIPS. This bonus can be realized, and penalties can be avoided, by engaging the Digital Medicine toolkit provided through the RxUniverse platform. The platform can be utilized to automate quality activities such as those that (1) gather patient experience data to improve practices, (2) provide online scheduling, and (3) support appointment reminders and transitions of care. Coupled with the analytics provided by the MIPS Score Simulator, the joint offering by MyMipsScore and Rx.Health provides a single solution for practitioners to capitalize on providing high-quality care to patients.
“MyMipsScore’s vision from the beginning has been to provide a solution that enables healthcare providers to understand value-based reimbursement programs and make informed strategic decisions,” said Dr. Pawan Jindal, Founder of MyMipsScore. “Aligning with a partner that is recognized as a leader in Digital Medicine will empower our users to implement interventional programs with minimal effort to execute those decisions.”
Rx.Health will highlight this exciting partnership at the upcoming Health 2.0 conference in California starting on October 1. At the conference, Rx.Health co-founder Dr. Ashish Atreja will participate in a panel discussion with other leaders from the Nation’s top hospitals discuss the transformative power of innovation within health systems.
Dr. Atreja himself is a leading authority on value-based transformation through digital tools, having recently authored a comprehensive article in the Summer 2017 edition of the Healthcare Financial Management Association magazine.
There’s a growing movement across the country calling for people to put down their mobile devices to promote human connectivity. However, there is a lack of awareness that smartphones can help individuals deal with a prevalent condition that often precludes them from social interaction: depression.
A recent study led by top research institutions found that certain smartphone apps were effective in significantly reducing depressive symptoms in patients struggling with mental disorders. Researchers at Australia’s National Institute of Complementary Medicine, along with colleagues at Harvard Medical School, the University of Manchester and the Black Dog Institute, published their findings in a paper titled, “The efficacy of smartphone-based mental health interventions for depressive symptoms: a meta-analysis of randomized controlled trials.”
The study aggregated and analyzed 18 eligible randomized controlled trials of 22 smartphone apps. These apps were then implemented in tests involving more than 3,400 male and female participants between the ages of 18 and 59. Participants’ mental conditions ranged from minor to major depression, bipolar disorder, anxiety and insomnia. Treatment offered by the apps varied, with participants receiving daily emails encouraging prompt engagement, audio exercises, and the promotion of learnt techniques to deal with challenging situations.
Joseph Firth, the study’s lead author and a postdoctoral research fellow at NICM, wrote, “Combined with the rapid technological advances in this area, these devices may ultimately be capable of providing instantly accessible and highly effective treatments for depression, reducing the societal and economic burden of this condition worldwide.” Firth continues, “the increasing media promotion and accessibility of apps for mental health now presents a ‘duty of care’ issue towards ensuring that people have information and understanding of evidence-based digital treatments for depression.”
As smartphones have become ubiquitous, and as health systems consolidate, employing mobile health solutions may provide a method for treating underserved patient populations. The NICM-led study highlights the potential opportunity to provide affordable and highly accessible care to patients, as nearly half of the world’s population lives in countries with a physiatrist/patient ratio of 1 to 100,000.
While the debate will no doubt continue around time spent on screens, the counterargument has emerged that digital therapies can augment physical and mental well-being. However, there is no evidence to suggest that using apps alone can outperform standard psychological therapies or reduce the need for antidepressant medications.
Signaling a new era of patient care, Responsive Health is leading the most innovative names in healthcare as the company rebrands to Rx.Health. This positions Rx.Health as the platform for prescribing of Digital Medicine, and ushers in a new model of patient engagement through the company’s flagship product, RxUniverse.
“Value-based care has changed everything, so it’s important that clinicians rethink the way they interact with patients on a monthly, weekly, and even daily basis,” Rx.Health CEO Ed Berde said. “Rx.Health symbolizes the new reality that providers need to extend patient care beyond the clinical visit and embrace Digital Medicine as the most effective means of providing continuous care.”
Through the RxUniverse prescription platform, Rx.Health is providing the solution for health systems to embrace Digital Medicine as they adapt to value-based care. RxUniverse aggregates the most effective Digital Medicine solutions available on the market onto a single platform, allowing healthcare organizations and their care teams to engage with patients and prescribe Digital Medicine directly to patients at the point of care.
“The Rx symbol literally represents prescribing, so it’s so fitting to have it as our brand as we move into the era of prescribing Digital Medicine,” said VP of Operations, Andy Pfau. “Digital Medicine includes evidence-based apps, care plans, health education, and other proven solutions. RxUniverse allows doctors to prescribe Digital Medicine as easily as traditional medication. Relaunching as Rx.Health lets the world know we’re the future patient care.”
Physicians and patients want Digital Medicine as a component of their comprehensive care plans, however until now health systems lacked the platform to adopt solutions. A previously published research report found only 2 percent of patients in the largest U.S. hospitals are currently using hospital-provided mobile health apps. This is a surprising statistic given recent confirmation that more than three quarters of hospital-related physicians and more than two thirds of patients are eager to engage Digital Medicine as a means to better care. Now, through Rx.Health’s RxUniverse platform, health systems can transform their hospital care by implementing Digital Medicine across departments.
“The failure to align mobile apps to the services patients demand could cost each hospital more than $100 million in lost revenue per year, which is a staggering statistic,” noted Rx.Health VP of Sales and Growth, Mark Cittadino. “Rx.Health provides a validated digital toolkit on a single platform. We boost financial performance by helping hospitals end the hemorrhaging of revenue while realizing additional income.”
The .health domain is already attracting other industry-leading brands such as Mayo Clinic, United Healthcare, Pfizer, Apple, Google, and Amazon. Registrants who adopt .health domains will be subject to stringent terms and policies to ensure the integrity of the extension and deter misuse, allowing a validated experience for individuals accessing health information online.
“Responsive Health was already known as a leader in the field of health innovation,” said Jose Rasco, CEO of dotHealth LLC. “By rebranding as Rx.Health, they’re sending a message to the world that Digital Medicine represents the future of health, and they are the channel for prescribing Digital Medicine. Anyone who works in healthcare immediately recognizes the importance of a .health domain. We’re thrilled to have Rx.Health as a flagship anchor in the .health domain space.”
Rx.Health is defining the delivery of Digital Medicine. Formerly Responsive Health, a spinoff from the Mount Sinai Health System, Rx.Health is dedicated to facilitating the digital revolution in healthcare. Rx.Health’s flagship product, RxUniverse, is the first enterprise-based Digital Medicine delivery system that enables physicians to prescribe evidence-based mobile health applications, multi-media education, wearables, and therapeutics to patients at the point of care. Information on Rx.Health and RxUniverse is available at http://Rx.Health and http://RxUniverse.com, or follow Rx.Health on Twitter @Rx_Health and LinkedIn at https://www.linkedin.com/company/Rx-Health.
On Sept. 12 members of the Responsive Health team engaged with CFOs and other c-level healthcare executives to discuss leading fiscal topics in healthcare at the NJHFMA’s Regulatory and Reimbursement Update Conference. Responsive Health VP of Corporate Development, Pavan Choksi, and the company’s new VP of Sales, Mark Cittadino, engaged in several discussions focused on value-based care initiatives and their budgetary implications for health systems.
“It’s buzzworthy in 2017 to talk about the switch from fee-for-service to value-based care, but people typically don’t go into the weeds to discuss how that switch changes the way c-level executives view their financials,” Choksi said. “Events like this provide a rare forum to better understand the latest rules and regulations to maximize reimbursements and improve overall financial performance.”
Front and center at the conference were discussions around CMS’ final ruling on the Medicare Inpatient Prospective Payment System for the 2018 fiscal year. Steve Frankenbach, the Senior Director of Network Reimbursement at St. Luke’s University Health Network, led a discussion that included a detailed explanation of how acute and long-term care hospitals are affected by the ruling. Frankenbach outlined how specifications in the new ruling, which go into effect for all discharges starting Oct. 1, will create an estimated increase of $2.4 billion in Medicare revenue.
Brian Herdman, who serves as the Operations Manager for Financial Reimbursement Services at CBIZ KA Consulting Services, spoke about how the patient experience has changed under value-based care. According to Herdman, hospital staff now must take into careful consideration a patient’s preferences when implementing post-discharge care. This represents a paradigm shift from the traditional system under the fee-for-service model, when care was strictly left to the discretion of a healthcare provider with little to no input from a patient’s perspective.
Attendance at the conference allowed Choksi and Cittadino to build the relationship between Responsive Health and NJHFMA further. Responsive Health recently contributed a comprehensive article to the Summer 2017 quarterly edition of NJHFMA’s Focus Magazine. That article served as a call to action for practitioners to prepare for the looming MARCA/MIPS deadlines in order to avoid penalties and collect maximum reimbursement.